Wound Care - EMEA | Statista Market Forecast

Wound Care - EMEA

EMEA

Highlights

Revenue in the Wound Care market amounts to US$1.34bn in 2024. The market is expected to grow annually by 0.46% (CAGR 2024-2028).
In global comparison, most revenue is generated United States (US$1bn in 2024).
In relation to total population figures, per person revenues of US$0.55 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureMethodology

The Wound Care market in EMEA is experiencing significant growth and development due to a variety of factors. Customer preferences in the region are driving the demand for advanced wound care products.

Patients are increasingly seeking products that promote faster healing, reduce pain, and minimize scarring. This has led to a shift away from traditional wound care methods towards more innovative and technologically advanced solutions. Additionally, with an aging population in many countries in the region, there is a greater need for wound care products that cater to the specific needs of elderly patients, such as products that address chronic wounds and promote mobility.

Trends in the market reflect the increasing adoption of advanced wound care products. This includes the use of products such as dressings with antimicrobial properties, negative pressure wound therapy, and bioengineered skin substitutes. These products offer improved outcomes and reduced healing times, making them highly attractive to both healthcare professionals and patients.

Furthermore, there is a growing focus on the development of personalized wound care solutions, tailored to the individual needs of patients. Local special circumstances in the region also contribute to the growth of the Wound Care market. For example, the prevalence of chronic diseases such as diabetes and obesity is increasing in many countries in EMEA.

These conditions often lead to chronic wounds, creating a higher demand for wound care products. Additionally, the region has a well-established healthcare infrastructure, with a strong emphasis on research and development. This enables the development and adoption of innovative wound care solutions.

Underlying macroeconomic factors further support the growth of the Wound Care market in EMEA. The region has a large and growing population, providing a significant customer base for wound care products. Additionally, increasing healthcare expenditure and government initiatives aimed at improving healthcare access and quality contribute to the market growth.

Furthermore, the presence of major healthcare companies and research institutions in the region fosters innovation and drives the development of new wound care products. In conclusion, the Wound Care market in EMEA is experiencing robust growth and development due to customer preferences for advanced wound care products, trends in the market towards innovative solutions, local special circumstances such as the prevalence of chronic diseases, and underlying macroeconomic factors that support healthcare investment and innovation.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.